Feb 10, 2026
Helsinki stocks were broadly flat, but earnings triggered sharp company-level moves. The OMX Helsinki 25 was little changed in the afternoon, masking wide dispersion between winners and losers.
Optomed, a Finnish medical technology company focused on handheld eye imaging devices and AI-based screening software, saw the harshest reaction. Shares fell nearly 24% after the group revealed another year of losses, despite double-digit revenue growth.
Optomed CEO Juho Himberg noted that “operational performance in Q4 2025 was solid” and stressed that the comparison period had been “exceptionally strong.” Investors, however, focused on profitability, with EBITDA still negative and cash flow under pressure.
LapWall, an industrial producer of prefabricated roof and wall elements for construction, also traded lower after publishing its full-year figures. The company proposed a dividend, but margins weakened as construction markets remained soft.
LapWall CEO Jarmo Pekkarinen described 2025 as “strategically significant,” adding that LapWall had focused on “those factors that determine the company’s success in the long term,” particularly competitiveness and capacity investments.
Inderes, which provides investor relations services, was steadier. Shares slipped marginally after the company reported improving momentum in the final quarter. CEO Mikael Rautanen said: “Growth picked up in the final quarter of the year to 12%, with profitability improving significantly,” while acknowledging that international expansion continues to weigh on results.
At Remedy Entertainment, a globally known video game developer behind franchises such as Control and Alan Wake, the tone was more optimistic. Interim CEO Markus Mäki said: “After a few challenging quarters, Q4 was both positive and profitable,” pointing to rising royalties and the strong reception of Control Resonant.
